The New York Times recently published an article expressing grave concern about the use of puberty blockers to treat gender dysphoria in transgender adolescents. Unfortunately, the reporting ignored evidence and important context to weave a narrative portraying puberty blockers as far more risky than they actually are.
Four years ago, I wrote about an essentially negative study looking at whether acupuncture could alleviate joint pain caused by aromatase inhibitors, a common treatment for estrogen-sensitive breast cancer. The study's back, and it doesn't look any more positive.
A study comparing a statin drug and six common supplements to placebo shows that only the drug lowers bad cholesterol.
Last week, antivaxxers were all over social media after Tucker Carlson touted a "revelation" that the phase 3 clinical trial used to support licensure of the Pfizer COVID-19 vaccine didn't examine its ability to block transmission as meaning that its inability to block transmission had been "covered up". It wasn't, and antivaxxers are ignoring everything we've learned over the last two years...